title: Abiraterone acetate (Zytiga) for metastatic castration-resistant prostate cancer.
mesh_terms: D000726:Androgen Antagonists / Q000493:pharmacokinetics / Q000627:therapeutic use; D000736:Androstenes; D000737:Androstenols / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000818:Animals; D006801:Humans; D008297:Male; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D013254:Steroid 17-alpha-Hydroxylase / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D000726:Androgen Antagonists; D000736:Androstenes; D000737:Androstenols; D013254:Steroid 17-alpha-Hydroxylase; C089740:abiraterone